Address: Cochabamba 2525, (C1252AAO), Buenos Aires,Argentina
Tel: +54 11 4122 5800
Web: http://www.baliarda.com.ar/
A very strong local Argentinean pharmaceutical company, Baliarda was founded over 70 years ago, and is still family-owned and run. Capitalizing on Argentina’s strong human resource base, the company is dedicated to innovation and development of the best quality products at the best prices for patients. This philosophy of innovation extends to every level within the company, which has a very strong and dynamic sales-force countrywide, and state-of-the-art management software to track sales and meetings. Baliarda is even developing its own machinery to increase productivity and efficiency within their plant. Building on a solid reputation in the industry, Baliarda are an example of how hard work, a vision, quality and efficiency lead to success.
Corticosteroids, Pnemonology, Gastroenterology, Phlebology
“Argentina’s health system is in agony” In March 2002, amidst an economic crisis and national healthcare emergency the then Minister of Health Gines Gonzales Garcia declared “Argentina’s health system is…
Santiago Garcia Belmonte, president of Biosidus, discusses how global regulatory trends are driving change in the Argentinian biotech industry, as well the new direction his firm has taken over the…
The Executive Director of Argentina’s social security health provider, PAMI, discusses the institutions mission and evolution, as well as his hopes for the future of the Argentinian health system. What…
Francisco Molinari, CEO of Argentina’s most sophisticated biotech group discusses Argentina’s competitiveness in the global biosimilar market, the current constraints limiting innovation in Argentina, and his company’s recent transition from…
Medtronic’s Regional Director for the South Cone shares with us the story of the company’s impressive success since the rebirth of their Argentinian affiliate in 2007, and indicates that Argentinian…
The national coordinator for Argentina’s ministry of health Plan Remediar discusses developing a professional management culture in the country’s public health centers, and the programs wider role in the public…
Dräger’s Sub Regional manager discusses the challenges of dealing with the fragmented and diverse Argentine healthcare sector, and some of the various strategies and approaches the firm uses to succeed…
The COO of Argentina’s largest logistics provider explains how the firm evolved into the preeminent player in the pharmaceutical logistics market, transporting roughly half of all pharmaceutical and medical device…
Alicia Alvarez Berkenwald, Partner at the specialized intellectual property services firm Berken IP, gives an introduction to the Argentinian IP environment, common strategies used to bypass obstacles, and Berken IP’s…
The vice president of Laboratorio Tuteur highlights the position of his company as the leaders in specialty products in Argentina. Could you please give us an historical overview of Laboratorio…
Founder of Promedon Marcelo Olmedo discusses innovation in Cordoba, and the birth and success of Promedon, a flagship company of the region. How do you see the importance of…
Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, is a potentially life-threatening illness currently afflicting eight to ten million people worldwide. Latin America is home to the vast majority…
See our Cookie Privacy Policy Here
